


Healthcare News Roundup: Mergers & Acquisitions
HSMN NewsFeed - 2 May 2013
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
HSMN NewsFeed - 15 Apr 2013
Angiotech announces close of sale of Interventional Products Business to Argon Medical Devices, Inc.
Angiotech announces close of sale of Interventional Products Business to Argon Medical Devices, Inc.
HSMN NewsFeed - 15 Apr 2013
Miraculins Executes Term Sheet to Acquire the SCOUT DS(R) Non-Invasive Diabetes Screening Technology
Miraculins Executes Term Sheet to Acquire the SCOUT DS(R) Non-Invasive Diabetes Screening Technology
HSMN NewsFeed - 28 Mar 2013
Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
HSMN NewsFeed - 25 Mar 2013
Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc.
Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc.
